Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study

Atherosclerosis. 2020 Apr:299:64-66. doi: 10.1016/j.atherosclerosis.2020.02.020. Epub 2020 Feb 29.

¹ Department of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
² Department of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Neurology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Radiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
³ Department of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Cardiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: [email protected].

No abstract available

Keywords: Cardiovascular disease; Dyslipidaemia guidelines; Epidemiology; Evidence; Primary prevention; Statin.

Publication types